Abstract:We aimed at assessing anxiety‐ and depressive‐like behaviors in Wistar‐Kyoto (WKY) rats and determining whether these were associated to changes in levels of neuroinflammatory markers (Iba‐1, CD86, Ym1, GFAP, S100A10) and mediators (interleukins IL‐1β, IL‐6, TNF‐α) in the prefrontal cortex (PFC), hippocampus, and amygdala. We found that WKY rats displayed increased anxiety‐like behaviors, but inconsistent depressive‐like behaviors, and severely diminished locomotor activity. Additionally, we found no neuroinflammatory changes in any of the assessed regions. Our data question some aspects of the validity of the WKY model of major depressive disorder (MDD) and highlight the necessity of carefully interpreting data considering the evidenced locomotor alterations. Reductionistic research on depressive disorders has been hampered by the limitations of animal models. Recently, it has been hypothesized that neuroinflammation is a key player in depressive disorders. The Wistar‐Kyoto (WKY) rat is an often‐used animal model of depression, but no information so far exists on its neuroinflammatory profile. As such, we compared male young adult WKY rats to Wistar (WS) controls, with regard to both behavioral performance and brain levels of key neuroinflammatory markers. We first assessed anxiety‐ and depression‐like behaviors in a battery consisting of the Elevated Plus Maze (EPM), the Novelty Suppressed Feeding (NSFT), Open Field (OFT), Social Interaction (SIT), Forced Swim (FST), Sucrose Preference (SPT), and Splash tests (ST). We found that WKY rats displayed increased NSFT feeding latency, decreased OFT center zone permanence, decreased EPM open arm permanence, decreased SIT interaction time, and increased immobility in the FST. However, WKY rats also evidenced marked hypolocomotion, which is likely to confound performance in such tests. Interestingly, WKY rats performed similarly, or even above, to WS levels in the SPT and ST, in which altered locomotion is not a significant confound. In a separate cohort, we assessed prefrontal cortex (PFC), hippocampus and amygdala levels of markers of astrocytic (GFAP, S100A10) and microglial (Iba1, CD86, Ym1) activation status, as well as of three key proinflammatory cytokines (IL‐1β, IL‐6, TNF‐α). There were no significant differences between strains in any of these markers, in any of the regions assessed. Overall, results highlight that behavioral data obtained with WKY rats as a model of depression must be carefully interpreted, considering the marked locomotor activity deficits displayed. Furthermore, our data suggest that, despite WKY rats replicating many depression‐associated neurobiological alterations, as shown by others, this is not the case for neuroinflammation‐related alterations, thus representing a novel limitation of this model.

Circuit-wide proteomics profiling reveals brain region-specific protein signatures in the male WKY rats with endogenous depression

Unmoving and uninflamed: Characterizing neuroinflammatory dysfunction in the Wistar‐Kyoto rat model of depression

Proteomic characterization of the medial prefrontal cortex in chronic restraint stress mice

Hypothalamic Gene Expression and Postpartum Behavior in a Genetic Rat Model of Depression

Key Risk Genes Identified From the Postmortem Brain of Patients With Major Depressive Disorder and Their Potential Clinical Applications

Brain Structure and Synaptic Protein Expression Alterations after Antidepressant Treatment in a Wistar–Kyoto Rat Model of Depression

Transcriptome comparative analysis of amygdala-hippocampus in depression: A rat model induced by chronic unpredictable mild stress (CUMS)

Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum

Behavioral and Molecular Responses to Electroconvulsive Shock Differ Between Genetic and Environmental Rat Models of Depression.

Entorhinal cortex-based metabolic profiling of chronic restraint stress mice model of depression

Gender-Related Hippocampal Proteomics Study from Young Rats after Chronic Unpredicted Mild Stress Exposure

Validation of Wistar-Kyoto rats kept in solitary housing as an animal model for depression using voxel-based morphometry

Comparative Proteomic Characterization of Ventral Hippocampus in Susceptible and Resilient Rats Subjected to Chronic Unpredictable Stress

Microelectrode Arrays for Detection of Neural Activity in Depressed Rats: Enhanced Theta Activity in the Basolateral Amygdala

Quantitative Proteomic Study of the Plasma Reveals Acute Phase Response and LXR/RXR and FXR/RXR Activation in the Chronic Unpredictable Mild Stress Mouse Model of Depression

Multi-omics Analysis of the Amygdala in a Rat Chronic Unpredictable Mild Stress Model of Depression

Proteomics study of stress-induced depression in rat model based on the two dimensional electrophoresis

iTRAQ-based proteomics suggests LRP6, NPY and NPY2R perturbation in the hippocampus involved in CSDS may induce resilience and susceptibility

Studying molecular mechanisms of depression by a rat model based on gene expression profiles and gene functional modules

Multiple integrated social stress induces depressive-like behavioral and neural adaptations in female C57BL/6J mice